How the Duration Period of Erythropoietin Treatment Influences the Oxidative Status of Hemodialysis Patients

Background: End-stage renal disease is a state of enhanced oxidative stress (OS) and hemodialysis (HD) and renal anemia further augment this disbalance. Anemia correction with erythropoietin (EPO) may improve oxidative status. However, there is no evidence of time dependent effects of EPO therapy on...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Dimitrijevic, Zorica M., Cvetkovic, Tatjana P., Djordjevic, Vidojko M., Pavlovic, Dusica D., Stefanovic, Nikola Z., Stojanovic, Ivana R., Paunovic, Goran J., Velickovic-Radovanovic, Radmila M.
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2012
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3491441/
https://ncbi.nlm.nih.gov/pubmed/23136545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.4910
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares